Informação sobre produto
Nome:
Salinomycin
Sinónimos:
- [u'Coxistac', u'K 364', u'salinomycin monosodium salt', u'Coxistac', u'Bio-cox', u'53003-10-4', u'Procoxacin', u'UNII-62UXS86T64', u'CHEBI:80025', u'62UXS86T64', u'Salinomycine [INN-French]', u'Salinomycinum [INN-Latin]', u'Salinomicina [INN-Spanish]', u'K 364', u'HSDB 7032', u'Salinomicina', u'Salinomycine', u'Salinomycinum', u'AHR 3096', u'EINECS 258-290-1', u'Salinomycin [INN:BAN]', u'Salinomycin (Procoxacin)', u'Procoxacin (TN)', u'Salinomycin (INN)', u'AC1MJ3UE', u'SCHEMBL36890', u'CHEMBL1208572', u'DTXSID4048486', u'KQXDHUJYNAXLNZ-XQSDOZFQSA-N', u's2352', u's8129', u'ZINC85540254', u'Salinomycin (from Streptomyces albus)', u'CCG-208535', u'CS-1299', u'E716', u'HY-15597', u'C15690', u'D08502', u'W-6068', u'J-524236', u'SR-05000002207-3', u'Salinomycin, from Streptomyces albus, >=98% (HPLC)', u'Salinomycin, Ready Made Solution, from Streptomyces albus, >=98% (HPLC)', u'(2R)-2-[(2R,5S,6R)-6-[(2S,3S,4S,6R)-6-[(2S,5S,7R,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5?.3?]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-5-methyloxan-2-yl]butanoic acid', u'(2R)-2-[(2R,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.5^{7}.3^{5}]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-5-methyloxan-2-yl]butanoic acid', u'Salinomycin sodium salt', u'Salinomycin [BAN:INN]', u'salinomycin monosodium salt', u'C42H70O11', u'CID3085092', u'CS-O-14400', u'C42-H70-O11', u'A3785', u'C010327', u'SR-05000002207']
- (2R)-2-((5S)-6-{5-((10S,12R)-2-((6S,5R)-5-Ethyl-5-Hydroxy-6-Methylperhydro-2H-Pyran-2-Yl)-15-Hydroxy-2,10,12-Trimethyl-1,6,8-Trioxadispiro(4.1.5.3)Pentadec-13-En-9-Yl)(1S,2S,3S,5R)-2-Hydroxy-1,3-Dimethyl-4-Oxoheptyl}-5-Methylperhydro-2H-Pyran-2-Yl)Butanoic Acid
- (2R)-2-{(5S,6R)-6-[(2S,3S,4S,6R)-6-{(2S,5R,7S,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl}-3-hydroxy-4-methyl-5-oxooctan-2-yl]-5-methyltetrahydro-2H-pyran-2-yl}butanoic acid
- 1,6,8-Trioxadispiro[4.1.5.3]pentadecane, salinomycin deriv.
- Antibiotic 61477
- Coxistac
- Stereoisomer of α-ethyl-6-[5-[2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl]-2-hydroxy-1,3-dimethyl-4-oxoheptyl]tetrahydro-5-methyl-2H-pyran-2-acetic acid
- sodium (2R)-2-{(2R,5S,6R)-6-[(1S,2S,3S,5R)-5-{(2S,5S,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl}-2-hydroxy-1,3-dimethyl-4-oxoheptyl]-5-methyltetrahydro-2H-pyran-2-yl}butanoate
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Indagoo
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
750.9986
Fórmula:
C42H70O11
Pureza:
98%
Cor/forma:
Solid
InChI:
InChI=1S/C42H70O11/c1-11-29(38(46)47)31-15-14-23(4)36(50-31)27(8)34(44)26(7)35(45)30(12-2)37-24(5)22-25(6)41(51-37)19-16-32(43)42(53-41)21-20-39(10,52-42)33-17-18-40(48,13-3)28(9)49-33/h16,19,23-34,36-37,43-44,48H,11-15,17-18,20-22H2,1-10H3,(H,46,47)/t23-,24-,25+,26-,27-,28-,29+,30-,31+,32+,33+,34+,36+,37-,39-,40+,41-,42-/m0/s1
Chave InChI:
KQXDHUJYNAXLNZ-XQSDOZFQSA-N
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
